blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1831199

EP1831199 - MMP inhibitors [Right-click to bookmark this link]
Former [2007/37]NOVEL COMPOUNDS
[2011/31]
StatusNo opposition filed within time limit
Status updated on  21.12.2012
Database last updated on 25.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2007/37]
Inventor(s)01 / GABOS, Balint
AstraZeneca R & D Lund
S-221 87 Lund / SE
02 / LUNDKVIST, Michael
AstraZeneca R & D Lund
S-221 87 Lund / SE
03 / MUNCK AF ROSENSCHÖLD, Magnus
AstraZeneca R & D Lund
S-221 87 Lund / SE
04 / SHAMOVSKY, Igor
AstraZeneca R & D Lund
S-221 87 Lund / SE
05 / ZLATOIDSKY, Pavol
AstraZeneca R & D Lund
S-221 87 Lund / SE
 [2007/37]
Representative(s)Wahlström, Christer, et al
AstraZeneca
Global Intellectual Property
151 85 Södertälje / SE
[N/P]
Former [2007/37]Wahlström, Stig Christer Gunnar, et al
AstraZeneca Global Intellectual Property
151 85 Södertälje / SE
Application number, filing date05815745.414.12.2005
[2007/37]
WO2005SE01917
Priority number, dateSE2004000308517.12.2004         Original published format: SE 0403085
[2007/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006065215
Date:22.06.2006
Language:EN
[2006/25]
Type: A1 Application with search report 
No.:EP1831199
Date:12.09.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 22.06.2006 takes the place of the publication of the European patent application.
[2007/37]
Type: B1 Patent specification 
No.:EP1831199
Date:15.02.2012
Language:EN
[2012/07]
Search report(s)International search report - published on:SE22.06.2006
(Supplementary) European search report - dispatched on:EP23.03.2009
ClassificationIPC:C07D401/14, A61K31/444, A61K31/506, A61P11/06, A61P19/02, A61P35/00, A61P9/10, C07D471/04
[2007/37]
CPC:
C07D401/14 (EP,KR,US); A61K31/4709 (KR); A61P11/00 (EP);
A61P11/06 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D471/04 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/37]
Extension statesAL17.07.2007
BA17.07.2007
HR17.07.2007
MK17.07.2007
YU17.07.2007
TitleGerman:MMP-Inhibitoren[2011/31]
English:MMP inhibitors[2011/31]
French:Inhibiteurs de la MMP[2011/31]
Former [2007/37]NEUE VERBINDUNGEN
Former [2007/37]NOVEL COMPOUNDS
Former [2007/37]NOUVEAUX COMPOSES
Entry into regional phase17.07.2007National basic fee paid 
17.07.2007Search fee paid 
17.07.2007Designation fee(s) paid 
17.07.2007Examination fee paid 
Examination procedure17.07.2007Examination requested  [2007/37]
01.07.2009Despatch of a communication from the examining division (Time limit: M06)
22.12.2009Reply to a communication from the examining division
28.07.2011Communication of intention to grant the patent
17.11.2011Fee for grant paid
17.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.07.2009
Opposition(s)16.11.2012No opposition filed within time limit [2013/04]
Fees paidRenewal fee
02.01.2008Renewal fee patent year 03
28.03.2008Renewal fee patent year 04
04.01.2010Renewal fee patent year 05
03.01.2011Renewal fee patent year 06
02.01.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.12.2005
ES15.12.2007
AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
[2014/34]
Former [2014/27]ES15.12.2007
AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2013/33]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2013/07]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/50]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/49]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
RO15.02.2012
SI15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/48]BE15.02.2012
CY15.02.2012
EE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/41]BE15.02.2012
CY15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/39]BE15.02.2012
FI15.02.2012
LT15.02.2012
LV15.02.2012
PL15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/37]BE15.02.2012
FI15.02.2012
LT15.02.2012
PL15.02.2012
GR16.05.2012
IS15.06.2012
PT15.06.2012
Former [2012/36]LT15.02.2012
GR16.05.2012
IS15.06.2012
Former [2012/34]LT15.02.2012
IS15.06.2012
Former [2012/33]LT15.02.2012
Cited inInternational search[A]WO02074767  (ASTRAZENECA AB [SE], et al);
 [A]WO02074750  (ASTRAZENECA AB [SE], et al);
 [A]WO2004024718  (ASTRAZENECA AB [SE], et al);
 [A]WO2004024715  (ASTRAZENECA AB [SE], et al);
 [A]WO2004033632  (BRISTOL MYERS SQUIBB CO [US], et al);
 [A]WO2004108086  (BRISTOL MYERS SQUIBB CO [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.